Original document(25 pages) Authorized document(25 pages) 中文版
    The present invention discloses a new process of sophoricoside from Chinese medicinal material sophora fruit, the medicine preparation of sophoricoside and the new medicinal use of sophoricoside in preventing and treating coronary heart disease, angina, myocardial ischemia, cerebral thrombosis and other diseases. The preparation process features are that only water and ethanol is used and has low cost and no environmental pollution and is safe and suitable for industrial production.
Application Number
申请号
02149470 Application Date
申请日
2002.11.21
Title 名称 Prepn process, medicine prepn and new medicinal use of sophoricosids
Publication Number
公开号
1417220 Publication Date
公开日
2003.05.14
Approval Pub. Date Granted Pub. Date 2005.01.05
International Classification 分类号 A61K35/78,A61P9/10,C07H17/07
Applicant(s) Name
申请人
Jilin Tianyao Sci-Tech Co., Ltd.
Address 地址 130103
Inventor(s) Name 发明人 Zhao Quancheng, Han Daqing
Attorney & Agent 代理人 zhang tao

  
Ganoderma applanatum polysaccharide, its preparation and medicine composition using said compound as active component
Method for preparing yam saponin, medicinal preparation and new usage in medication
Antineoplastic effect and medicine prepn of dioscin
Novel process for preparing diosgenin
Process for extracting general platycodoside and platycoligenin D from platycodon root, its medical application and its Chinese medicine
Application of evodiamine in the preparation of medicine
Anti-tumor function of sophorine and its medicine preparation
Echinocystic acid preparation method、medicinal preparation and new use as medicine
Process for extracting triterpenic acid from gleditschia, and medical use and Chinese medicine of triterpenic acid
Application of hederagenin in preparing anihyperlipemia medicine
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.